08 Feb 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Ansell's recently constructed 16,000 square foot state-of-the-art R&D facility in the Biyagama Export Zone, located outside Colombo, Sri Lanka, is now fully operational.
The Sri Lanka R&D center is the fourth center of excellence that Ansell has installed, thus adding to its existing facilities in Malaysia, Mexico and North America. The investment in additional R&D resources and the decision to create and co-locate its R&D centers with the Ansell manufacturing structure underline the company's commitment to accelerate innovation and to faster serve the emerging unmet needs of customers worldwide.
"Ansell has a long track record of manufacturing high quality industrial and medical products in Sri Lanka, and new product development will now complement manufacturing and expand our presence in the region," said Mr Magnus Nicolin , managing director and CEO, Ansell Limited, "This is a measure of the confidence in and commitment of Ansell to the talent and future of Sri Lanka."
In total, 30 science and technology specialists have been recruited, bringing along the latest technology and knowledge on both the material side as well as the manufacturing processes side.
"With over two decades in Sri Lanka and over 2000 employees, Ansell has been a key player in Sri Lanka's export industry for a very long time," said Ms Sujatha Weerakoon, director general of the Sri Lanka Export Development Board. "I am confident that the new R&D Center will greatly help further establish the role of Ansell as a local business leader while also benefitting the national economy."